Changing the face of medicine with Moderna
Release Date:
What was it like being on the inside of Moderna in 2020? Lavina Talukdar, Vice President of Investor Relations at Moderna, talks the race to the COVID-19 vaccine, how she landed her dream role with zero prior investor-relations experience and what the future holds for the biotech firm that is changing the face of medicine.
Changing the face of medicine with Moderna